| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.2 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | 0.23 | 0.2 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |